Educational information only — not a diagnosis or treatment recommendation.
Content last checked: Jul 15, 2026·Sources & review
A breast cancer diagnosis creates many questions at once. You do not need to solve them all today — start from the decision you are facing now. The usual path runs diagnosis → subtype → treatment order → surgery or systemic choices.
Your decision map · about 3 minutes
A diagnosis creates many questions at once. You do not need to solve them all today. This is a navigation map, not a reading list — find the decision you are facing now, open one guide, then return when the next question comes up.
Quick start
Jump to a situation below — same map, fewer steps to choose.
Optional foundation
You can start with a decision situation below even if you do not know all the details yet. Open a short guide only if you want basics first.
Your first decisions usually depend on confirming the cancer type, subtype, and what information is needed before treatment choices.
You may also need to consider
Do I need genetic counseling before breast cancer surgery?Understand how surgery, systemic therapy, and treatment timing may fit together.
You may also need to consider
How should radiation factor into my breast cancer treatment?Questions about side effects, work, fertility, family, cost, and whether the plan is workable day to day.
You may also need to consider
How should radiation factor into my breast cancer treatment?When you want another perspective, more expertise, or a clearer understanding before moving forward.
You may also need to consider
When should I consider breast cancer care abroad?Metastatic disease, progression, or a plan that stopped working.
You may also need to consider
What treatment options fit my breast cancer subtype?Monitoring, late effects, and life after treatment — including what to sort out if cancer returns.
You may also need to consider
Should I get a second opinion before surgery or systemic therapy?For search and first visits
Short answers that point to one decision guide — not a full reading list.
You do not need every answer today. First clarify subtype (ER/PR/HER2), stage or extent, and whether treatment should start before or after surgery — then prepare a short question list.
First steps after diagnosis →Not always. Many people wait for subtype, staging, or genetics results when those could change the plan. Ask what must happen this week versus what can wait.
Urgency and waiting →Often yes, when the pending results could change surgery or treatment order. Waiting for useful information is different from delaying care without a plan — ask if your wait is safe.
Subtype results before treatment →Start from your situation on the map above. Early forks are usually subtype, treatment order (before vs after surgery), and whether genetics could change the operation.
Treatment before or after surgery →A focused second opinion can help before irreversible surgery or major systemic therapy. Confirmation of the current plan is also a useful outcome — ask how urgent your next step is.
Second opinion guide →Breast cancer decisions often follow diagnosis → subtype biology → stage → surgery/local treatment → systemic sequencing. This center is building a situation-based Decision Journey (starting with newly diagnosed) so patients can leave with a clear next step — not an encyclopedia.
Understanding breast cancer subtype
Orient to HR+, HER2+, and triple-negative biology, what to find on your pathology report, and how subtype changes the first plan.
Open Understanding Subtype →Understanding breast cancer stage
Orient to early, locally advanced / nodes, and advanced extent — why stage changes options and sequencing, not a prognosis table.
Open Understanding Stage →Treatment Landscape
Orient to surgery, radiation, endocrine, chemo, targeted/immuno, and reconstruction families — so later comparisons make sense.
Open Treatment Landscape →Cross-border care is a branch of the journey when a specific capability is missing locally — not a default destination.
Editorial examples of how patients compare options — not verified personal testimonials.
Complete node graph for structure and deep links — most people can stay with the situation map and nearby decisions above.
Diagnosis confirmed
Confirm what is known, which results are outstanding (subtype, imaging, genetics when relevant), and which decisions are time-sensitive.
Why this matters: This matters because early sequencing mistakes are hard to undo — you need to know which results change the first plan.
Decision questions
Illustrative journey
Decision fork — paths can run in parallel
Subtype / receptor testing
Make sure receptor, HER2, and related biology results are complete enough to shape first-line choices — or decide when waiting is not safe.
Why this matters: This matters because subtype often changes which systemic options and sequencing make sense.
Decision questions
Neoadjuvant vs adjuvant
Decide whether systemic therapy should start before surgery (neoadjuvant) or after — a breast-distinctive fork.
Why this matters: This matters because sequencing can affect surgery options, response assessment, and what information you need first.
Decision questions
Surgery choice
Compare breast-conserving surgery and mastectomy when both may be reasonable — including genetics and reconstruction timing as hang-card context.
Why this matters: This matters because two oncologically sound options can still feel very different personally.
Decision questions
Illustrative journey
Another review
Decide whether another expert review helps before surgery or systemic therapy.
Why this matters: This matters when the plan feels irreversible, recommendations conflict, or you want more confidence.
Germline genetics
Whether genetic counseling and BRCA-class testing should happen before surgery — and how results may change the operation.
Why this matters: Germline risk is not the same as tumor subtype — it can change surgery and family implications.
Decision questions
Branches to
Systemic options by subtype
Compare systemic options for your subtype (HR+ / HER2+ / TNBC) — goals, sequencing, and trade-offs — not a flat drug menu.
Why this matters: This matters because subtype forks the conversation more sharply than a single “best chemo” list.
Decision center facets
Branches to
Reconstruction
How reconstruction timing and choices fit into the cancer decision.
Why this matters: Reconstruction is part of the surgery conversation for many people — not a separate afterthought only.
Branches to
Radiation
How radiation decisions factor into breast-conserving treatment, mastectomy plans, and reconstruction timing.
Why this matters: Radiation often follows lumpectomy and is sometimes needed after mastectomy — assumptions can tip the whole local plan.
Decision questions
Branches to
Care team
How to choose a breast cancer care team or center — expertise, coordination, and hybrid setups.
Why this matters: Fragmented teams can conflict on surgery, sequencing, radiation, and reconstruction even when each specialist is skilled.
Decision questions
Metastatic disease
Options when breast cancer is metastatic or stage IV — control, symptoms, and quality of life.
Why this matters: Goals and trade-offs shift when disease is advanced — patients need a clear decision path that is not “nothing can be done.”
Decision questions
Recurrence
What to sort out if breast cancer returns after treatment — a new decision point, not an auto-replay.
Why this matters: Recurrence is a new decision point — location, prior therapy, and re-testing shape the next options.
Decision questions
Personal goals
Bring personal goals, daily life, and priorities into breast cancer treatment conversations.
Why this matters: Cancer decisions are about your life, not only your cancer — priorities make trade-offs clearer.
Decision questions
Practical fit
Pointer into Care Team, Systemic options, and Quality of Life — whether a plan can work with cost, travel, time, and support.
Why this matters: Practical factors belong in the conversation. Open the matching decision page rather than treating logistics as a separate encyclopedia.
Decision questions
Clinical trial decision
Decide whether a clinical trial should be part of your discussion — compared with other options, not as a last resort.
Why this matters: Trials are a decision option at multiple points — evaluate purpose, evidence, risks, subtype fit, and practical burden.
Decision questions
Follow-up monitoring
After active treatment, clarify what to monitor, when to contact the team, and how ongoing medicines fit.
Why this matters: The end of treatment is not the end of care — patients need a clear plan for visits, symptoms, late effects, and life after cancer.
Decision questions
International option
Only explore cross-border care when a specific capability, trial, or specialty review is missing locally.
Why this matters: This matters only when a specific capability is missing locally — not as a default upgrade.
Decision questions